rAAV2tYF-GRK1-hRPGRco, Control — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-06-30 in 8d
ESTIMATED |
READOUT
A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injec
Phase 2/3 · X-Linked Retinitis Pigmentosa |
Beacon Therapeutics | rAAV2tYF-GRK1-hRPGRco, Control |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|